Equillium Inc (EQ)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$2.21-0.45%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · EQ
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||
| Revenues | — | — | 41.1 | 36.1 | 15.8 | — | — | — | — |
| Operating Expenses & Income | |||||||||
| R&D Expenses | — | — | — | 37.0 | 37.5 | 26.4 | 19.4 | 17.6 | 4.9 |
| Operating Income | (19.3) | (23.6) | (8.3) | (14.5) | (62.1) | (37.8) | (29.5) | (26.7) | (8.6) |
| Earnings from Continuing Operations | |||||||||
| Interest & Investment Income | 1.4 | 0.8 | 1.4 | 2.3 | 0.4 | 0.1 | 0.5 | 1.4 | 0.3 |
| Other Non-Operating Income / Expenses | — | — | — | 1.8 | (0.4) | (1.3) | (0.3) | 1.1 | (4.6) |
| EBT, Incl. Unusual Items | — | (22.4) | (7.7) | (12.8) | (62.4) | (39.1) | (29.8) | (25.6) | — |
| Income Tax Expense | — | — | 0.4 | 0.6 | 0.0 | 0.0 | 0.0 | — | — |
| Net Income | |||||||||
| Net Income | (18.0) | (22.4) | (8.1) | (13.3) | (62.4) | (39.1) | (29.8) | (25.6) | (13.3) |
| Per Share | |||||||||
| Basic EPS | (0.16) | (0.39) | (0.23) | (0.38) | (1.85) | (1.36) | — | — | — |
| Diluted EPS | (0.16) | (0.39) | (0.23) | (0.38) | (1.85) | (1.36) | — | — | — |
| Basic Weighted Avg Shares | 111.8 | 57.3 | 35.4 | 34.7 | 33.7 | 28.8 | — | — | — |
| Diluted Weighted Avg Shares | 111.8 | 57.3 | 35.4 | 34.7 | 33.7 | 28.8 | — | — | — |
| Supplemental | |||||||||
| EBITDA | — | — | — | — | (62.0) | (37.7) | (29.5) | (26.7) | (8.6) |
| EBIT | (19.3) | (23.6) | (8.3) | (14.5) | (62.1) | (37.8) | (29.5) | (26.7) | (8.6) |
| Effective Tax Rate | — | — | — | -4.5% | 0.0% | 0.0% | 0.0% | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.